Table 2.
Factors associated with of delayed ART initiation among PLHIV referred for ART at Mulago ISS clinic in the test and treat era
| Variable | Category | n = 48 (%) | cOR (95% CI) | P-value | aOR (95% CI) | P-value |
|---|---|---|---|---|---|---|
| Age group | 15–24 | 4 (8.3) | 1.0 | |||
| 25–34 | 22 (45.8) | 0.8 (0.3–2.5) | 0.730 | |||
| > = 35 | 22 (45.8) | 1.3 (0.3–5.4) | 0.765 | |||
| Sex | Female | 30 (62.5) | 1.0 | |||
| Male | 18 (37.5) | 1.0 (0.5–1.9) | 0.960 | |||
| Highest level of Education | None/primary | 21 (43.8) | 1.0 | 1.0 | ||
| Secondary | 17 (35.4) | 1.0 (0.5–1.9) | 0.906 | 0.9 (0.4–2.0) | 0.771 | |
| Tertiary | 10 (20.8) | 2.2 (0.9–5.1) | 0.075 | 2.4 (0.8–7.1) | 0.116 | |
| Employment status | Not employed | 4 (8.3) | 1.0 | |||
| Self employed | 27 (56.3) | 2.4 (0.8–7.3) | 0.114 | |||
| Formal employment | 17 (35.4) | 2.8 (0.9–8.9) | 0.075 | |||
| Marital status | Single | 26 (54.2) | 1.0 | |||
| Married | 22 (45.8) | 1.0 (0.6–1.9) | 0.884 | |||
| SES | Poorest | 17 (35.4) | 1.0 | 1.0 | ||
| Poor | 6 (12.5) | 0.5 (0.2–1.5) | 0.230 | 0.4 (0.1–1.5) | 0.173 | |
| Medium | 5 (10.4) | 0.4 (0.1–1.3) | 0.122 | 0.4 (0.1–1.2) | 0.101 | |
| Wealthy | 14 (29.2) | 0.6 (0.3–1.3) | 0.202 | 0.5 (0.2–1.3) | 0.150 | |
| Wealthiest | 6 (12.5) | 1.0 2.7 (0.8–8.6) | 0.093 | 2.5 (0.6–10.5) | 0.211 | |
| Place of HIV diagnosis | Public facility | 17 (35.4) | 1.0 | 1.0 | ||
| Private facility | 25 (52.1) | 3.1 (1.6–6.1) | 0.001 | 2.4 (1.1–5.5) | 0.037 | |
| Outreach | 6 (12.5) | 2.4 (0.8–7.3) | 0.114 | 2.9 (0.8–10.4) | 0.096 | |
| Counselling during HIV diagnosis | Both pre and post testing | 28 (58.3) | 1.0 | 1.0 | ||
| Either pre or post testing | 10 (20.8) | 2 (0.9–4.4) | 0.086 | 1.0 (0.4–2.5) | 0.933 | |
| None | 10 (20.8) | 5 (2.1–12.3) | < 0.001 | 1.3 (0.4–4.3) | 0.710 | |
| Accepted HIV positive results | Yes | 33 (68.8) | 1.0 | 1.0 | ||
| No | 15 (31.3) | 8.1 (3.6–18.3) | < 0.001 | 5.4 (2.0–15.0) | 0.001 | |
| Received a referral note to higher health facility | Yes | 24 (50.0) | 1.0 | 1.0 | ||
| No | 24 (50.0) | 5.3 (2.7–10.2) | < 0.001 | 1.7 (0.7–4.5) | 0.244 | |
| Received a follow-up phone call after referral from place of testing. | Yes | 15 (31.3) | 1.0 | 1.0 | ||
| No | 33 (68.8) | 4.3 (2.2–8.2) | < 0.001 | 2.8 (1.2–6.8) | 0.019 | |
| Baseline CD4 count before ART initiation. | < 200 cells/μL | 13 (27.1) | 1.0 | 1.0 | ||
| ≥200 cells/μL | 35 (72.9) | 1.4 (0.7–2.8) | 0.320 | 1.3 (0.6–2.9) | 0.515 | |
| HIV associated comorbidities | None | 44 (91.7) | 1.0 | |||
| Tuberculosis | 1 (2.1) | 0.2 (0.03–1.5) | 0.116 | |||
| Cryptococcal Meningitis | 3 (6.3) | 8.0 (1.3–49.3) | 0.025 |
n Number that delayed ART initiation, cOR Crude Odds Ratio, aOR Adjusted Odds Ratio, SES Social economic status